TAKEDA PHARMACEUTICAL COMPANY LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 49127
 
  
 
C07D HETEROCYCLIC COMPOUNDS 42113
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 4910
 
  
 
C07K PEPTIDES 35101
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 30108
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 2446
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 24143
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2273
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 15191
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 13141

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0072,758 5HT3 RECEPTOR ANTAGONISTSMay 31, 17Mar 15, 18[A61K, C07D, C07C]
2017/0319,565 METHODS AND DRUG PRODUCTS FOR TREATING ALZHEIMER'S DISEASEMay 22, 17Nov 09, 17[A61K, C12Q, C07D]
2017/0233,406 CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDESep 29, 15Aug 17, 17[C07D]
2017/0183,326 COCRYSTAL, PRODUCTION METHOD THEREOF, AND MEDICAMENT CONTAINING COCRYSTALDec 22, 16Jun 29, 17[A61K, C07D, C07C]
2017/0174,682 HETEROCYCLIC COMPOUNDMar 07, 17Jun 22, 17[C07D]
2017/0137,880 METHOD FOR TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDERMar 04, 15May 18, 17[A61K, C12Q]
2017/0065,553 ORALLY DISPERSIBLE TABLETNov 18, 16Mar 09, 17[A61K]
2017/0044,143 ISOINDOLINE-1-ONE DERIVATIVES AS CHOLINERGIC MUSCARINIC M1 RECEPTOR POSITIVE ALLOESTERIC MODULATOR ACTIVITY FOR THE TREATMENT OF ALZHEIMERS DISEASEApr 22, 15Feb 16, 17[C07D]
2017/0014,407 PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTON OR TREATMENT OF AN ATAXIC DISORDERMar 06, 15Jan 19, 17[A61K]
2016/0362,475 UTI FUSION PROTEINSFeb 23, 15Dec 15, 16[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920047 Cyclopropanamine compound and use thereofSep 20, 16Mar 20, 18[C07D]
9907789 Sustained-release preparationOct 19, 12Mar 06, 18[A61K]
9901546 Orally disintegrable tabletsMay 27, 14Feb 27, 18[A61K]
9890145 Heterocyclic compoundApr 25, 16Feb 13, 18[A61K, C07D, A61P]
9884875 Heterocyclic compound and use thereofOct 10, 16Feb 06, 18[C07D]
9878981 Method for producing heterocyclic compoundApr 09, 15Jan 30, 18[C07D, C07C]
9878989 Heterocyclic compoundJun 23, 16Jan 30, 18[C07F, C07D]
9868725 Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's diseaseApr 22, 15Jan 16, 18[A61K, C07D]
9856310 UTI fusion proteinsFeb 23, 15Jan 02, 18[A61K, C07K]
9834520 Heterocyclic compoundMar 13, 14Dec 05, 17[A61K, C07F, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0096,422 HETEROCYCLIC COMPOUNDAbandonedMar 23, 15Apr 06, 17[C07D, C07B]
2017/0015,654 PYRIDAZINE COMPOUNDAbandonedMar 11, 15Jan 19, 17[C07D]
2017/0016,139 Method for Producing Single Crystal of Polymer-Metal ComplexAbandonedAug 31, 16Jan 19, 17[C08F, C30B]
2016/0166,526 COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENTAbandonedFeb 19, 16Jun 16, 16[A61K]
2016/0159,773 HETEROCYCLIC COMPOUNDAbandonedJul 29, 14Jun 09, 16[C07D]
2016/0159,808 HETEROCYCLIC COMPOUNDAbandonedJul 23, 14Jun 09, 16[C07D]
9241945 Dry coated tabletWithdrawnNov 29, 12Jan 26, 16[A61K, A01N]
2015/0336,964 FUSED HETEROAROMATIC PYRROLIDINONESAbandonedJul 31, 15Nov 26, 15[A61K, C07D]
2015/0299,188 HETEROCYCLIC COMPOUNDAbandonedAug 23, 13Oct 22, 15[C07D]
2015/0203,464 COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENTAbandonedApr 02, 15Jul 23, 15[C07D]
2015/0157,609 SOLID PREPARATIONAbandonedMar 29, 12Jun 11, 15[A61K]
2015/0133,311 METHOD FOR ASSESSING ENDOMETRIOSISAbandonedMay 30, 13May 14, 15[C12Q]
2015/0126,533 ADMINISTRATION OF A RAF INHIBITOR AND A MEK INHIBITOR IN THE TREATMENT OF MELANOMAAbandonedMar 29, 13May 07, 15[A61K]
2015/0051,256 COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENTAbandonedOct 28, 14Feb 19, 15[C07D, C07C]
2014/0343,033 AZAINDOLE DERIVATIVESAbandonedAug 04, 14Nov 20, 14[A61K, C07D]
2014/0256,693 PYRROLO [1,2-C] IMIDAZOLE DERIVATIVES FOR USE IN THE PROPHYLAXIS OR TREATMENT OF CANCER WHICH IS REFRACTORY TO KNOWN CANCER THERAPIESAbandonedFeb 05, 14Sep 11, 14[A61K, C07D]
2014/0256,757 ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORSAbandonedMay 19, 14Sep 11, 14[A61K]
2014/0235,709 ORALLY DISPERSIBLE TABLETAbandonedJan 30, 14Aug 21, 14[A61K]
2014/0235,879 ORALLY DISPERSIBLE TABLETAbandonedJan 30, 14Aug 21, 14[C07D]
2014/0205,672 RELEASE CONTROL COMPOSITIONSAbandonedJan 17, 14Jul 24, 14[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.